JP Morgan Chase & Co Reiterates Overweight Rating for Puma Biotechnology Inc (PBYI) – The Cerbat Gem

Posted: Published on June 12th, 2017

This post was added by Dr P. Richardson


Morning Times
JP Morgan Chase & Co Reiterates Overweight Rating for Puma Biotechnology Inc (PBYI)
The Cerbat Gem
Puma Biotechnology Inc logo J P Morgan Chase & Co restated their overweight rating on shares of Puma Biotechnology Inc (NYSE:PBYI) in a report issued on Tuesday morning. J P Morgan Chase & Co currently has a $89.00 target price on the ...
Puma Biotechnology, Inc. (NasdaqGS:PBYI) Company Valuation & Investor ReviewUnion Trade Journal
Puma Biotechnology (PBYI) Research Analysts' Weekly Ratings UpdatesBNB Daily (blog)
Credit Suisse Group Reiterates $58.00 Price Target for Puma Biotechnology Inc (PBYI)Transcript Daily
Stock Observer -Sports Perspectives -SEC.gov
all 27 news articles »

Originally posted here:
JP Morgan Chase & Co Reiterates Overweight Rating for Puma Biotechnology Inc (PBYI) - The Cerbat Gem

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.